Altheus Therapeutics' Series B Round

Altheus Therapeutics raised a round of funding on March 12, 2012.

Altheus Therapeutics is developing Zoenasa Oral Controlled Release and Rectal Gel formulations as front-line therapies for the treatment of inflammatory bowel disease (IBD) with the initial focus on u…

Articles about Altheus Therapeutics' Series B Round: